Page not found

Search results

  1. Taking a bite out of Charcot-Marie-Tooth Disease

    ... types of CMT that don’t involve PMP22 at all. Schwann cells, the “bodyguards” of nerve cells, wrap around nerve fibers, providing ... manager of corporate alliances for Vanderbilt’s Center for Technology Transfer and Commercialization,  attended a global conference ...

    sommers - 03/18/2024 - 1:36pm

  2. Wolbachia genetic tools for population control of harmful insects

    ... that facilitates insect range expansion.   Technology Overview Vanderbilt researchers have developed several ... sterile male offspring, is significantly more effective and stable when introduced by transgenic males than by wild-type males infected ...

    cttc_admin - 02/15/2024 - 1:30pm

  3. Vanderbilt scientists, research translation experts attend CMT Global Research Convention

    ... conference,  Margaret Read , Vanderbilt’s  Center for Technology Transfer and Commercialization  general manager for corporate ... our data and model cell line work to nervous system cells.” Since then, the CMT Research Foundation has  invested  in ...

    sommers - 10/02/2023 - 11:32am

  4. Use of Fluid Shear Stress Treatment to Enhance T Cell Activation

    ... a technique to enhance immune cell activation by exposing cells to mechanical force while culturing. Proof-of-concept data indicate that ... effective in activating all types of T cells.   Technology Description Vanderbilt scientists have pioneered a method ...

    cttc_admin - 01/18/2024 - 9:10am

  5. ThermoFisher Scientific - Research Interest Areas

    ... analysis of recombinant protein quality; rapid bioburden technology; bioprocess data analytics; technologies for new biotherapeutic ... culture and cryo-preservation media for immune and stem cells; novel characterization assays and analytics Food safety and ...

    cttc_admin - 01/30/2024 - 12:26pm

  6. Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University

    ... 16 other important protein markers found expressed in tumor cells and surrounding immune cells wherein immunotherapy treatments can be ... and protein biomarker platform and LDTs, Theralink’s technology targets multiple areas of oncology and drug development. In addition ...

    sommers - 04/24/2023 - 1:45pm

  7. The yin and yang of cell signaling

    ... Lawrence Marnett , PhD, and colleagues used CRISPR-Cas9 technology to generate stable knock-outs of LYPLA1 and/or LYPLA2 in mouse neuroblastoma cell lines. ...

    sommers - 02/21/2019 - 9:51am

  8. From Concept to Commercialization: Dr. Paul Yock

    ... for Biodesign, dedicated to advanced training in medical technology innovation. Join us for an open discussion with Dr. Yock on biodesign, medical technology innovation, and his entrepreneurial journey. Registration is ...

    sommers - 03/25/2024 - 3:02pm

  9. Spinach protein and blackberry dye give juice to biohybrid solar cells

    ... increasing the voltage of spinach-derived biohybrid solar cells developed by Vanderbilt researchers by up to a factor of 20. The ... near that of today’s silicon solar cells. Biohybrid technology is at an early stage, comparable to silicon solar cells of 30 to 40 ...

    sommers - 03/05/2018 - 8:49am

  10. Rethinking drug efficacy: research aims to improve drug development

    ... Postdoctoral Fellow in 2023, are developing a startup with technology that will allow drug developers to test the impact of ... altering the current drug development procedures, the technology has potential to facilitate the creation of entirely novel drug ... of the basic science behind drug mechanisms. The technology will benefit both drug development and fundamental scientific ...

    sommers - 03/11/2024 - 8:54am